FDA Blocked Melanoma Drug As Confusion Reigned Under Makary
By Arthur Allen and KFF Health News HealthDay ReportersSATURDAY, May 16, 2026 (HealthDay News) — The U.S. Food and Drug Administration’s recent decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw that the drug had prolonged the lives of a third of the …